terminal bet A novel, weak bromo and extra terminal domain bromodomain fragment ligand to a potent and selective second bromodomain inhibitor.. INCB057643 is a small-molecule BET inhibitor evaluated as monotherapy and in combination with ruxolitinib in pts with advanced malignancies.
Keunggulan terminal bet
- ✅ terminal bet Setiap Hari
- ✅ Tanpa Deposit Awal
- ✅ Bisa Dicoba Gratis
LOGIN 
WHATSAPP 
RTP LIVE
LIVECHAT